Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - teicoplanin, quantity: 400 mg - injection, powder for - excipient ingredients: sodium chloride - teicoplanin sandoz is indicated for the treatment of the following serious infections due to staphylococci or streptococci, which cannot be treated satisfactorily with less toxic agents, including beta-lactam antibiotics: bone (osteomyelitis); joints (septic arthritis); blood (non-cardiac bacteraemia, septicaemia).

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - teicoplanin, quantity: 400 mg - injection, powder for - excipient ingredients: sodium hydroxide; sodium chloride - teicoplanin is indicated for the treatment of the following serious infections due to staphylococci or streptococci, which cannot be treated satisfactorily with less toxic agents, including beta-lactam antibiotics: bone (osteomyelitis); joints (septic arthritis); blood (noncardiac bacteraemia, septicaemia).

Ireland - English - HPRA (Health Products Regulatory Authority)

generics (uk) limited - teicoplanin - pdr for soln inj/inf - 100 milligram - teicoplanin

Ireland - English - HPRA (Health Products Regulatory Authority)

generics (uk) limited - teicoplanin - pdr for soln inj/inf - 200 milligram - teicoplanin

Ireland - English - HPRA (Health Products Regulatory Authority)

generics (uk) limited - teicoplanin - pdr for soln inj/inf - 400 milligram - teicoplanin

Malta - English - Medicines Authority

ibigen s.r.l via fossignano, 2, 04011 aprilia (lt), italy - teicoplanin - powder and solvent for solution for infusion or injection oral solution - teicoplanin 200 mg - antibacterials for systemic use

Malta - English - Medicines Authority

ibigen s.r.l via fossignano, 2, 04011 aprilia (lt), italy - teicoplanin - powder and solvent for solution for infusion or injection oral solution - teicoplanin 400 mg - antibacterials for systemic use

Ireland - English - HPRA (Health Products Regulatory Authority)

hikma farmacêutica (portugal) s.a. - teicoplanin - powder for solution for injection/infusion - 200 milligram(s) - glycopeptide antibacterials; teicoplanin

Ireland - English - HPRA (Health Products Regulatory Authority)

hikma farmacêutica (portugal) s.a. - teicoplanin - powder for solution for injection/infusion - 400 milligram(s) - glycopeptide antibacterials; teicoplanin

Ireland - English - HPRA (Health Products Regulatory Authority)

noridem enterprises limited - teicoplanin - powder and solvent for solution for injection/infusion - 200 milligram(s) - glycopeptide antibacterials; teicoplanin - glycopeptide antibacterials - it is indicated in adults and in children from birth for the parenteral treatment of the following infections :
complicated skin and soft tissue infections,
bone and joint infections,
hospital acquired pneumonia,
community acquired pneumonia,
complicated urinary tract infections,
infective endocarditis,
peritonitis associated with continuous ambulatory peritoneal dialysis (capd)
bacteraemia that occurs in association with any of the indications listed above.